Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Regulus Therapeutics expands executive team

This article was originally published in Scrip

Executive Summary

Regulus Therapeutics has appointed Mary Glanville senior vice-president of human capital and Christopher Aker senior director of legal affairs and secretary. Ms Glanville will be responsible for recruitment and retention, and previously served for ten years as vice-president of human capital at Anadys Pharmaceuticals. Mr Aker will take responsibility for all legal, corporate and intellectual property matters, and most recently served as corporate counsel and senior director of administration at Phenomix.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts